| Ticker Details |
Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
|
| IPO Date: |
May 1, 2007 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$128.16M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 2.97%
|
| Avg Daily Range (30 D): |
$0.08 | 2.24%
|
| Avg Daily Range (90 D): |
$0.07 | 2.58%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.26M |
| Avg Daily Volume (30 D): |
.21M |
| Avg Daily Volume (90 D): |
.19M |
| Trade Size |
| Avg Trade Size (Sh.): |
163 |
| Avg Trade Size (Sh.) (30 D): |
137 |
| Avg Trade Size (Sh.) (90 D): |
187 |
| Institutional Trades |
| Total Institutional Trades: |
115 |
| Avg Institutional Trade: |
$1.68M |
| Avg Institutional Trade (30 D): |
$4.62M |
| Avg Institutional Trade (90 D): |
$2.94M |
| Avg Institutional Trade Volume: |
.18M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.39M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
297.23K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$1.04
|
$1.16
|
$.32
|
|
Diluted EPS
|
$1
|
$1.13
|
$.31
|
|
Revenue
|
|
$M
|
$M
|
|
Gross Profit
|
|
$M
|
$M
|
|
Net Income / Loss
|
$43.85M
|
$48.39M
|
$13.26M
|
|
Operating Income / Loss
|
$-13.01M
|
$-2.43M
|
$-2.49M
|
|
Cost of Revenue
|
|
$M
|
$M
|
|
Net Cash Flow
|
$10.08M
|
$36.38M
|
$-38.62M
|
|
PE Ratio
|
3.46
|
|
|
|
|
|
